triazoles has been researched along with Crohn Disease in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (58.82) | 24.3611 |
| 2020's | 7 (41.18) | 2.80 |
| Authors | Studies |
|---|---|
| D'Haens, G; Galien, R; Grant, E; Liu, J; Roblin, X; Serone, A; Woo, J; Yoon, OK; Zhuo, L | 1 |
| Kim, JW; Kim, SY | 1 |
| Colombel, JF; D'Haens, GR; Lee, S; Rimola, J; Serone, A; Taylor, SA | 1 |
| Rogler, G | 1 |
| Argollo, M; Dal Buono, A; Danese, S; Roda, G | 1 |
| Allocca, M; Correale, C; Danese, S; Fiorino, G; Furfaro, F; Gabbiadini, R; Gilardi, D; Peyrin-Biroulet, L; Zilli, A | 1 |
| Berinstein, JA; Cushing, KC; Higgins, PDR; Huang, S; Johnson, LA; Rodansky, ES; Spence, JR; Steiner, CA | 1 |
| Boland, BS; Vermeire, S | 1 |
| Labetoulle, R; Paul, S; Roblin, X | 1 |
| Mountifield, R | 1 |
| Al Asmi, MM; Al-Hussaini, AA; Alshahrani, DA; Faqeehi, HY | 1 |
| Blanc, J; Brys, R; Christophe, T; Ciesielski, F; Clement-Lacroix, P; Deprez, P; Fletcher, SR; Galien, R; Geney, R; Jouannigot, N; Lepescheux, L; Menet, CJ; Nelles, L; Smits, K; Uhring, M; van der Aar, EM; Van Lommen, G; Van Rompaey, L; Vayssiere, B | 1 |
| González, GM; Hernández-Balboa, CL; Martínez-Reséndez, MF; Treviño-Rangel, RJ; Villanueva-Lozano, H | 1 |
| Ananthakrishnan, AN | 1 |
| Baranovsky, A; Goldis, A; Harrison, P; Hebuterne, X; Klopocka, M; Kuehbacher, T; Petryka, R; Roblin, X; Schreiber, S; Sike, R; Stoyanova, K; Tasset, C; Van der Aa, A; Vermeire, S; Wisniewska-Jarosinska, M | 1 |
| Bernardin, G; Burel-Vandenbos, F; Dunais, B; Gari-Toussaint, M; Guidicelli, S; Hyvernat, H | 1 |
| Daajani, NA; Farouq, MF; Ghanem, AT; Kamal, JS; Saadah, OI | 1 |
7 review(s) available for triazoles and Crohn Disease
| Article | Year |
|---|---|
The Era of Janus Kinase Inhibitors for Inflammatory Bowel Disease Treatment.
Topics: Adamantane; Colitis; Colitis, Ulcerative; Crohn Disease; Heterocyclic Compounds, 3-Ring; Humans; Inflammatory Bowel Diseases; Janus Kinase Inhibitors; Janus Kinases; Niacinamide; Piperidines; Pyridines; Pyrimidines; Pyrroles; Triazoles | 2021 |
Efficacy of JAK inhibitors in Crohn's Disease.
Topics: Crohn Disease; Heterocyclic Compounds, 3-Ring; Humans; Janus Kinase Inhibitors; Piperidines; Pyridines; Pyrimidines; Treatment Failure; Treatment Outcome; Triazoles | 2020 |
JAK selectivity: more precision less troubles.
Topics: Colitis, Ulcerative; Crohn Disease; Heterocyclic Compounds, 3-Ring; Humans; Janus Kinase 1; Janus Kinase 2; Janus Kinase 3; Janus Kinase Inhibitors; Naphthyridines; Nitriles; Piperidines; Pyridines; Pyrimidines; Signal Transduction; Triazoles; TYK2 Kinase | 2020 |
PK, PD, and interactions: the new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD.
Topics: Acetates; Animals; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Heterocyclic Compounds, 3-Ring; Humans; Indans; Indoles; Janus Kinase Inhibitors; Oxadiazoles; Piperidines; Pyridines; Pyrimidines; Quinolones; Sphingosine-1-Phosphate Receptors; Triazoles | 2020 |
Janus Kinase Antagonists and Other Novel Small Molecules for the Treatment of Crohn's Disease.
Topics: B-Lymphocytes; Colitis, Ulcerative; Crohn Disease; Humans; Indans; Janus Kinase 1; Janus Kinase Inhibitors; Oligonucleotides; Oxadiazoles; Piperidines; Pyridines; Pyrimidines; Pyrroles; Receptors, Lysosphingolipid; Smad7 Protein; T-Lymphocytes; Triazoles | 2017 |
Filgotinib for the treatment of Crohn's disease.
Topics: Crohn Disease; Disease Progression; Gastrointestinal Agents; Humans; Janus Kinase Inhibitors; Pyridines; Severity of Illness Index; Triazoles; Tumor Necrosis Factor-alpha | 2018 |
A case of pediatric gastrointestinal basidiobolomycosis mimicking Crohn`s disease. A review of pediatric literature.
Topics: Antifungal Agents; Child, Preschool; Crohn Disease; Diagnosis, Differential; Humans; Male; Pyrimidines; Triazoles; Voriconazole; Zygomycosis | 2013 |
1 trial(s) available for triazoles and Crohn Disease
| Article | Year |
|---|---|
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Analysis of Variance; Crohn Disease; Double-Blind Method; Drug Administration Schedule; Female; Humans; Janus Kinase Inhibitors; Male; Middle Aged; Pyridines; Treatment Outcome; Triazoles; Young Adult | 2017 |
9 other study(ies) available for triazoles and Crohn Disease
| Article | Year |
|---|---|
Effects of JAK1-Preferential Inhibitor Filgotinib on Circulating Biomarkers and Whole Blood Genes/Pathways of Patients With Moderately to Severely Active Crohn's Disease.
Topics: Biomarkers; C-Reactive Protein; Crohn Disease; Cytokines; Feces; Humans; Interleukin-6; Janus Kinase 1; Janus Kinase Inhibitors; Leukocyte L1 Antigen Complex; Pyridines; Severity of Illness Index; Triazoles | 2022 |
Filgotinib for the Treatment of Small Bowel Crohn's Disease: The DIVERGENCE 1 Trial.
Topics: Crohn Disease; Humans; Intestinal Diseases; Pyridines; Triazoles | 2023 |
AXL Is a Potential Target for the Treatment of Intestinal Fibrosis.
Topics: Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Crohn Disease; Fibrosis; Humans; Intestinal Failure; Intestines; Organoids; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Transforming Growth Factor beta1; Triazoles | 2021 |
Positioning biologics-A case-based discussion: Surgery and clinical trials.
Topics: Administration, Oral; Adult; Antibodies, Monoclonal, Humanized; Biosimilar Pharmaceuticals; Combined Modality Therapy; Crohn Disease; Digestive System Surgical Procedures; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Male; Pregnancy; Pregnancy, High-Risk; Pyridines; Randomized Controlled Trials as Topic; Recurrence; Severity of Illness Index; Triazoles; Ustekinumab; Young Adult | 2018 |
Triazolopyridines as selective JAK1 inhibitors: from hit identification to GLPG0634.
Topics: Adenosine Triphosphate; Animals; Arthritis; Chemistry, Pharmaceutical; Collagen; Crohn Disease; Crystallography, X-Ray; Cytokines; Dimerization; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Inhibitory Concentration 50; Janus Kinase 1; Kinetics; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Rats; Recombinant Proteins; Structure-Activity Relationship; Triazoles | 2014 |
An unusual case of Candida ciferrii fungemia in an immunocompromised patient with Crohn's and Mycobacterium bovis disease.
Topics: Adult; Antifungal Agents; Candida; Candidemia; Catheter-Related Infections; Catheterization, Central Venous; Crohn Disease; Female; Humans; Immunocompromised Host; Mycobacterium bovis; Treatment Outcome; Triazoles; Tuberculosis | 2016 |
Filgotinib for Crohn's disease-expanding treatment options.
Topics: Crohn Disease; Humans; Pyridines; Triazoles | 2017 |
Fatal peritonitis caused by Rhizopus microsporus.
Topics: Antifungal Agents; Colon; Crohn Disease; Fatal Outcome; Female; Humans; Intestinal Perforation; Middle Aged; Mucormycosis; Peritonitis; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2010 |
Gastrointestinal basidiobolomycosis in a child; an unusual fungal infection mimicking fistulising Crohn's disease.
Topics: Antifungal Agents; Child, Preschool; Colectomy; Crohn Disease; Diagnosis, Differential; Entomophthorales; Humans; Intestinal Diseases; Male; Pyrimidines; Triazoles; Voriconazole; Zygomycosis | 2012 |